top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 01/10/2016 Item size : 333679 bytes
Ehjcvp

In patients without left ventricular dysfunction and/or overt HF, three large studies (Heart Outcomes Prevention Evaluation, HOPE trial,3 the European trial on Reduction Of cardiac events with ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefania Paolillo, Pasquale Perrone Filardi

Date : 01/04/2015
Ehjcvp

Renin angiotensin system inhibitor and β-blocker combination therapy After treatment optimization, 78.5% patients were treated with combination therapy including both a RASI and a β-blocker; ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Jonathan De Blois, Morten Wang Fagerland, Morten Grundtvig, Anne Grete Semb, Lars Gullestad, Arne Westheim, Torstein Hole, ...

Date : 01/01/2015
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 21/04/2016